Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vastra Gotaland Region
Providence Health & Services
RayzeBio, Inc.
National Institutes of Health Clinical Center (CC)
Legend Biotech USA Inc
University of Wisconsin, Madison
Stanford University
M.D. Anderson Cancer Center
Emory University
Eisai Inc.
Jonsson Comprehensive Cancer Center
SAPU NANO (US) LLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences